Armistice Capital »

AFLAC Incorporated shares owned by Armistice Capital

Quarter-by-quarter ownership of AFLAC Incorporated (AFL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in AFLAC Incorporated

Tip: Access up to 7 years of quarterly data

All positions including AFLAC Incorporated held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AFLAC Incorporated by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $748k 6.4k 117.25

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding AFLAC Incorporated

Japan Post Holdings
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Geode Capital Management
Wells Fargo & Company
Morgan Stanley
Northern Trust
Goldman Sachs Group
Ubs Global Asset Management Americas
Dimensional Fund Advisors
Invesco
Legal & General Group
Charles Schwab Investment Management

View all funds holding AFLAC Incorporated